-
Feb 02, 2021
-
ACTG ADDS NEW AGENT TO ACTIV-2 TRIAL INVESTIGATING EARLY COVID-19 TREATMENTS
Jan 05, 2021
-
ACTG ADDS NEW AGENT TO ACTIV-2 TRIAL INVESTIGATING EARLY COVID-19 TREATMENTS
Jan 05, 2021
-
NIH RE-FUNDS ACTG FOR THE NEXT SEVEN YEARS
Dec 09, 2020
-
NIH RE-FUNDS ACTG FOR THE NEXT SEVEN YEARS
Nov 30, 2020
-
Nov 24, 2020
-
Nov 16, 2020
-
Nov 16, 2020
-
LANDMARK TRIAL DEMONSTRATES EFFECTIVENSS OF SHORTENED TB TREATMENT
Nov 05, 2020
-
ACTG REPRIEVE CHOSEN FOR VIIV GRANT
Jul 01, 2020
-
Jun 23, 2020
-
Jun 02, 2020
Press Releases & Announcements